Ifp Advisors, Inc Matinas Bio Pharma Holdings, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 643 shares of MTNB stock, worth $347. This represents 0.0% of its overall portfolio holdings.

Number of Shares

643

Previous 643 -0.0%

Holding current value

$347

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$0.63 - $0.96 $405 - $617	643 New	643 $2,000
Q2 2022 Aug 12, 2022	SELL	$0.63 - $0.96 $405 - $617	-643 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$0.75 - $1.1 $9,547 - $14,003	-12,730 Reduced 95.19%	643 $0
Q1 2021 Apr 30, 2021	BUY	$0.96 - $1.74 $3,238 - $5,869	3,373 Added 33.73%	13,373 $14,000
Q4 2020 Jan 25, 2021	BUY	$0.76 - $1.47 $7,600 - $14,700	10,000 New	10,000 $14,000
Q3 2020 Oct 29, 2020	BUY	$0.67 - $0.96 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$0.52 - $0.92 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$0.6 - $2.31 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$0.63 - $2.27 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$0.59 - $0.9 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$0.6 - $1.41 $1.07 Million - $2.5 Million	-1,775,000 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$0.53 - $1.11 $648,628 - $1.36 Million	1,223,828 Added 222.04%	1,775,000 $1.07 Million
Q2 2018 Aug 07, 2018	BUY	$0.42 - $0.74 $126,000 - $222,000	300,000 Added 119.44%	551,172 $0
Q4 2017 Jan 24, 2018	SELL	$1.1 - $1.54 $493,710 - $691,195	-448,828 Reduced 64.12%	251,172 $0
Q2 2017 Jun 03, 2019	BUY	N/A	700,000	700,000 $1.18 Million

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $117M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account